Increased 18F-2-Fluorodeoxysorbitol (18F-FDS) Activity in a Pituitary Spindle Cell Carcinoma

Clin Nucl Med. 2016 Dec;41(12):953-955. doi: 10.1097/RLU.0000000000001391.

Abstract

A 33-year-old woman presented with progressive visual loss. An MRI examination revealed a pituitary lesion which was suspicious of abscess. FDG and F-2-fluorodeoxysorbitol (F-FDS) PET were performed to differentiate malignancy from inflammation. FDS is a new tracer with potential in differentiating inflammatory tissues based on results from animal studies. However, intense tracer uptake was found in the pituitary in both PET studies. The lesion was proved to be spindle cell carcinoma following biopsy.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Carcinoma / diagnostic imaging*
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Magnetic Resonance Imaging
  • Pituitary Neoplasms / diagnostic imaging*
  • Positron Emission Tomography Computed Tomography
  • Radiopharmaceuticals
  • Sorbitol / analogs & derivatives

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
  • Sorbitol